Trial Details

Recruiting
Basic Information
Clinical ID c5555
Identifier NL-OMON25639
Trial Title Title *.Vaccinations in Immunocompromised Patients, Rabies Antibody Response after pre exposure prophylaxis - The VIPRAR study.
Trial URL Visit Original Page
Study Information
Study Results

NULL
Conditions Auto-immune diseases (Inflammatory bowel disease/rheumatoid arthritis)
Interventions We offer all eligible ICPs a three-dose rabies PrEP schedule on days 0, 7 and 21-28 intramuscularly, according to the current WHO guidelines for ICPs. At month 12, a 2-dose rabies PEP schedule will be administered intramuscularly at day 0 and day 3. S
Participant Information
Sponsor The International Society of Travel Medicine (ISTM)
City NULL
Country/Region NULL
Enrollment Criteria
Sex Requirement NOT SPECIFIED
Age Requirement NULL
Study Design
Study Type Interventional
Phase NULL
Time Information
Start Date NULL
Primary Completion Date NULL
Completion Date NULL